Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources
9th EDRN Steering Committee Meeting


Monday, February 02, 2004
8:00 am - 4:00 pmNetwork Consulting Committee (NCC) Meeting
(Off-Site at Renaissance Dallas Hotel) By Invitation Only
7:00 pm - 10:00 pmCollaborative Group Meeting
Topics of Discussion:
  • Preparation for 3rd Progress Report of the EDRN - Each Collaborative Group should designate one person lead the discussion and to contact Jacob Kagan
  • Progress on Gantt Chart
  • NIH Road Map and Role of EDRN
  • NCI Strategic Initiatives
  • Studies Approaching Validation in 2004

Tuesday, February 03, 2004
7:00 - 8:00 amRegistration and Continental Breakfast Opening of Steering Committee Meeting David Sidransky, Ian Thompson
8:00 - 8:15 amWelcome & Introduction
Adi Gazdar, MD, Professor of Pathology, University of Texas Southwestern Medical Center University of Texas Southwestern Officials
8:15 - 8:25 amApproval of June 2003 EDRN Steering Committee Minutes
David Sidransky
8:25 - 9:00 amNCI Perspectives Updates on NCI Strategic Initiatives
Anna Barker, PhD, Deputy Director for Strategic Initiatives, National Cancer Institute NIH Road Map Sudhir Srivastava
9:00 - 9:45 amNanotechnology and Early Detection Guest Speaker: Mauro Ferrari, PhD, Professor, Biomedical Engineering, Ohio State University
9:45 - 10:00 amBreak
10:00 - 11:00 amAccomplishments on EDRN Validation Studies: Topics of Discussion:
  • Progress on Validation Study Information Management System (VSIMS): Ziding Feng, Mark Thornquist, Marcy Winget, Don Johnsey
  • Status of Microsatellite Instability Assay (MSA) Validation Study: Mark Schoenberg, Mukesh Verma
  • Progress on SELDI for Prostate Cancer Detection: John Semmes, Jacob Kagan
11:00 - 12:00 pmProgress on Technology Developments for Early Detection: Topics of Discussion
  • Telomerase Assay Optimization: Peter Barker, Wendy Wang
  • Mitochondrial Chip: Peter Barker, Paul Wagner
  • Circulating DNA: Mukesh Verma
  • Lung Cancer Tissue Array-What is Next? David Chia
12:00 - 1:00 pmExecutive Committee meeting EC Members Only
12:00 - 2:00 pmLunch
2:00 - 2:45 amEDRN and Lung SPORE: Areas of Collaborative Opportunities: Guest Speaker: Paul A Bunn, MD, Director of the University of Colorado Cancer Center
3:00 - 7:00 pmFree Time Rooms available for ad-hoc meetings: NB2102 (General Session Room) NB2402/ NB2403/ NB2100A
7:00 - 9:00 pmSubcommittee Meetings: June 2004 Scientific Workshop Communication & Collaborative Subcommittees Chairs: Patrice Watson, David Fishman Delineation of Responsibilities for Large Scale Validation Study: Prioritization Subcommittee: William Bigbee, Chair Topics for Discussion:
  • Role of the Initiating Investigator
  • Role of the Participating CEC
  • Role of the DMCC
  • Role of NCI
  • Role of BVL and BDL

Wednesday, February 04, 2004
7:00 - 8:00 amContinental Breakfast
8:00 - 8:45 amResources and Opportunities for Collaboration
Guest Speaker: Joe Gray, Lawrence Berkeley National Laboratory
8:45 - 10:45 amBiological Specimen Resources and Collaboration: Policies and Procedures
Douglas Reding, PLCO
Mark Thornquist, CARET
Carol Kasten-Sportes, CGN (DCCPS)
Cheryl Marks, MMHCC
9:45 - 10:00 amBreak
10:45 - 12:15 pmGI Collaborative Group Showcase Dean Brenner, Chair (plus 2 members of this Group)
12:15 am- 1:00 pmCollaborative Group Reports
1:00 - 1:45 pmSubcommittee & Liaison Reports
1:45 pmAdjourn

Back to top